Editorial: Immunity in the development of anti-cancer drug resistance
Saved in:
Main Authors: | Ya Meng (Author), Haitao Wang (Author), Xuebing Li (Author), Xinwei Wu (Author), Heng Sun (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
by: Chunlan Zhang, et al.
Published: (2023) -
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
by: Jing-Bo Zhou, et al.
Published: (2023) -
Editorial: Anti-inflammatory drug development focusing on immune mediated diseases
by: José Fernando Oliveira-Costa, et al.
Published: (2024) -
Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
by: Huan Xiao, et al.
Published: (2021) -
Editorial: Adaptive immune resistance in cancer therapy
by: Aimin Jiang, et al.
Published: (2023)